The tables below support the Kaiser Family Foundation February 2017 brief titled,“The
Effects of Medicaid Expansion under the ACA: Updated Findings from a Literature …

At the ten year mark since the passage of the Affordable Care Act (ACA), a substantial body
of research has investigated effects of the Medicaid expansion on coverage; access to care …

On October 30 and 31, 2018, the Committee on Medication-Assisted Treatment (MAT) for
Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the …

Drug overdose is now the leading cause of injury death in the United States. Most overdose
fatalities involve opioids, which include prescription medication, heroin, and illicit fentanyl …

Policy Points This article reconceptualizes our understanding of the opioid epidemic and
proposes six strategies that address the epidemic's social roots. In order to successfully …

We develop new tools for estimating the causal effects of treatments or instruments that
combine multiple sources of variation according to a known formula. Examples include …

At least 2.3 million people in the US have an opioid use disorder, less than 40% of whom
receive evidence-based treatment. Buprenorphine used as part of medication-assisted …

We estimate the effect of health insurance coverage on opioid use disorder treatment
utilization and availability by exploiting cross-state variation in effective dates of Medicaid …

Even with great advances in behavioral health policy in the last decade, the problems of
mental illness and addiction persist in the United States—so more needs to be done. In this …

Importance Expanding Medicaid eligibility could affect prescriptions of buprenorphine with
naloxone, an established treatment for opioid use disorder, and opioid pain relievers …